Company / Gross Profit
ORTHOPEDIATRICS CORP Gross Profit History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$111.3M
FY2025
5-year range
$54.6M / $111.3M
FY2021-FY2025
Trend
+22.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 8 consecutive years, from $22M in FY2017 to $111M in FY2025.
Based on SEC 10-K filings.
$111M in FY2025 with a 5-year CAGR of +21.1%.
Improved from $73M to $111M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +26.4%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- ORTHOPEDIATRICS CORP's gross profit has grown for 8 consecutive years.
- 5-year CAGR of +21.1%, indicating consistent growth.
- In FY2025, gross profit increased 22.7% year-over-year.
- Lowest gross profit in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.3M | +22.7% |
| FY2024 | $90.7M | +23.5% |
| FY2023 | $73.4M | +33.4% |
| FY2022 | $55.0M | +0.8% |
| FY2021 | $54.6M | +28.0% |
| FY2020 | $42.7M | +23.9% |
| FY2019 | $34.5M | +30.7% |
| FY2018 | $26.4M | +21.9% |
| FY2017 | $21.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026